{"id":291077,"date":"2026-10-07T09:31:57","date_gmt":"2026-10-07T04:01:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=291077"},"modified":"2026-10-07T09:31:57","modified_gmt":"2026-10-07T04:01:57","slug":"why-gland-pharma-ltd-share-price-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/","title":{"rendered":"Gland Pharma Ltd. (GLAND) Share Price Hits Fresh 52-Week High at Rs 3,055"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em>Gland Pharma Ltd. (GLAND) share price reached a fresh 52-week high of Rs 3,055 today and later stood at Rs 3,050, up 1.43% from the previous close. Market cap was Rs 48,067.66 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Gland Pharma Share Price is in focus after the stock touched a fresh 52-week high of Rs 3,055 and last traded at Rs 3,050, up Rs 43.10 or 1.43% from the previous close of Rs 3,006.90. Gland Pharma Ltd. has a market capitalisation of Rs 48,067.66 crore, placing the move in a sizeable healthcare name that is already close to the day\u2019s top. The stock opened at Rs 3,021.05 and moved between Rs 3,021 and Rs 3,055 in early trade.For readers tracking Gland Pharma Share Price Today, the fresh 52-week high is the key event, while Gland Pharma Share Price news flow, valuation and sector comparison help frame the move.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Gland_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Gland Pharma Share Price Today: Price Action Analysis\">Gland Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Why_Gland_Pharma_Ltd_GLAND_May_Be_Moving_Today\" title=\"Why Gland Pharma Ltd. (GLAND) May Be Moving Today\">Why Gland Pharma Ltd. (GLAND) May Be Moving Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Gland_Pharma_Ltd_GLAND_Fundamental_Analysis\" title=\"Gland Pharma Ltd. (GLAND) Fundamental Analysis\">Gland Pharma Ltd. (GLAND) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Why_Investors_Are_Watching_Gland_Pharma\" title=\"Why Investors Are Watching Gland Pharma\">Why Investors Are Watching Gland Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#About_Gland_Pharma\" title=\"About Gland Pharma\">About Gland Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#What_is_Gland_Pharma_Share_Price_today\" title=\"What is Gland Pharma Share Price today?\">What is Gland Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Why_did_Gland_Pharma_Share_Price_touch_a_fresh_52-week_high\" title=\"Why did Gland Pharma Share Price touch a fresh 52-week high?\">Why did Gland Pharma Share Price touch a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#What_is_the_market_capitalisation_of_Gland_Pharma\" title=\"What is the market capitalisation of Gland Pharma?\">What is the market capitalisation of Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#How_is_Gland_Pharma_Share_Price_valued_versus_its_sector\" title=\"How is Gland Pharma Share Price valued versus its sector?\">How is Gland Pharma Share Price valued versus its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#What_do_EPS_and_book_value_mean_for_Gland_Pharma_Share_Price\" title=\"What do EPS and book value mean for Gland Pharma Share Price?\">What do EPS and book value mean for Gland Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Is_dividend_yield_relevant_for_Gland_Pharma_Share_Price\" title=\"Is dividend yield relevant for Gland Pharma Share Price?\">Is dividend yield relevant for Gland Pharma Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#How_does_Gland_Pharma_compare_with_peer_companies\" title=\"How does Gland Pharma compare with peer companies?\">How does Gland Pharma compare with peer companies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#What_sector_does_Gland_Pharma_operate_in\" title=\"What sector does Gland Pharma operate in?\">What sector does Gland Pharma operate in?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-gland-pharma-ltd-share-price-52-week-high-today-2026\/#Track_Gland_Pharma_Share_Price_on_Univest\" title=\"Track Gland Pharma Share Price on Univest\">Track Gland Pharma Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gland_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Gland Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,050<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,006.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 43.1 (+1.43%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,021.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,055<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,021<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,067.66 crore<\/td>\n<\/tr>\n<\/table>\n<p>Gland Pharma Ltd. (GLAND) traded at Rs 3,050 versus the previous close of Rs 3,006.9, a rise of 1.43%. The stock opened at Rs 3,021.05, reached a high of Rs 3,055 and touched a low of Rs 3,021.<\/p>\n<p>Gland Pharma Share Price Today shows a firm start to the trading day, with the stock opening above the previous close and then touching Rs 3,055, which is also the fresh 52-week high. The current trade at Rs 3,050 sits Rs 43.10 above the previous close of Rs 3,006.90, and the day range has been tight so far, between Rs 3,021 and Rs 3,055. That makes the current Gland Pharma Share Price sit just Rs 5 below the day\u2019s peak. The setup is relevant because the stock is already trading close to the fresh yearly high rather than drifting away from it. In Gland Pharma Share Price terms, the market is clearly pricing the stock near its intraday high, and that keeps the event in focus for stock analysis on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Gland_Pharma_Ltd_GLAND_May_Be_Moving_Today\"><\/span><strong>Why Gland Pharma Ltd. (GLAND) May Be Moving Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div class=\"news-context\">According to recent news reports, one item was reported at 07 Oct, 08:56 am: Nomura initiated a Buy rating on Gland Pharma with a target price of Rs 3,750. The brokerage said it is focusing on the company\u2019s strategic pivot towards CDMO, biologics and in-licensing, and it projected a roughly 20% revenue CAGR. It also highlighted stabilization at Cenexi and growth in biologics and specialty as key drivers, while noting that valuation expansion is anticipated with strengthening CDMO capabilities. The market data confirms the fresh 52-week high, but it does not establish a single confirmed cause.<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Gland_Pharma_Ltd_GLAND_Fundamental_Analysis\"><\/span><strong>Gland Pharma Ltd. (GLAND) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,067.66 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">43.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 68.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 644.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.67%<\/td>\n<\/tr>\n<\/table>\n<p>Gland Pharma Ltd. (GLAND) fundamental metrics show P\/E 43.96x, P\/B 4.67x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Gland Pharma Ltd. has a market capitalisation of Rs 48,067.66 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 43.96x, P\/B at 4.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.67%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 31.86x, median ROE of 11.78%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">43.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.58x to 695.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.67x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,067.66 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 789.87 crore<\/td>\n<\/tr>\n<\/table>\n<p>Gland Pharma Ltd. (GLAND) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Gland Pharma Ltd. (GLAND) has a P\/E ratio of 43.96x, which is above the benchmark median of 31.86x, a difference of +37.98%. On its own, the P\/E gap is a valuation reference point, not a trading call.<\/p>\n<p>Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.78%, a difference of -10.36%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.61%, a difference of +9.92%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Anthem Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ANTHEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48,009.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.62<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,506.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.7<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glaxosmithkline Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAXO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46,319.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">43.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ajanta Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AJANTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">43,590.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55,907.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<\/table>\n<p>Gland Pharma Ltd. (GLAND) has a P\/E ratio of 43.96x compared with the displayed peer median of 39.38x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.56% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 48,067.66 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Gland_Pharma\"><\/span><strong>Why Investors Are Watching Gland Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Gland Pharma Share Price touched a fresh 52-week high of Rs 3,055 and last traded at Rs 3,050.<\/li>\n<li>Gland Pharma Share Price is up Rs 43.10, or 1.43%, from the previous close of Rs 3,006.90.<\/li>\n<li>Gland Pharma Share Price has a P\/E ratio of 43.96 and a P\/B ratio of 4.67.<\/li>\n<li>Gland Pharma Share Price shows ROE of 10.56% and ROCE of 14.96%.<\/li>\n<li>Gland Pharma Share Price is compared with same-industry peers in healthcare and pharmaceuticals &#038; drugs.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Gland_Pharma\"><\/span><strong>About Gland Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. Gland Pharma Share Price readers usually track it alongside the company\u2019s valuation, revenue and return metrics because the stock is part of a broader pharmaceutical set. The latest reported quarterly revenue stands at Rs 1,800.27 crore for Jun 2026, while the company\u2019s market capitalisation is Rs 48,067.66 crore. Gland Pharma Share Price is therefore often discussed in the context of earnings quality, book value and capital returns rather than only intraday movement.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gland_Pharma_Share_Price_today\"><\/span><strong>What is Gland Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma Share Price last traded at Rs 3,050, after touching a fresh 52-week high of Rs 3,055. The stock is up 1.43% from the previous close of Rs 3,006.90 in early trade.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Gland_Pharma_Share_Price_touch_a_fresh_52-week_high\"><\/span><strong>Why did Gland Pharma Share Price touch a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>A news item on the same day discussed a broker rating and target price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Gland_Pharma\"><\/span><strong>What is the market capitalisation of Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma has a market capitalisation of Rs 48,067.66 crore. That places Gland Pharma Share Price in a large company bracket within the healthcare universe, without changing the valuation questions that matter to investors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Gland_Pharma_Share_Price_valued_versus_its_sector\"><\/span><strong>How is Gland Pharma Share Price valued versus its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma Share Price trades at a P\/E of 43.96 versus the same-industry median of 31.86 and a P\/B of 4.67 versus 2.93. ROCE at 14.96% is above the benchmark median of 13.61%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_and_book_value_mean_for_Gland_Pharma_Share_Price\"><\/span><strong>What do EPS and book value mean for Gland Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS of Rs 68.41 shows earnings attributable to each share, while book value of Rs 644.16 shows accounting net worth per share. Both figures are important when assessing Gland Pharma Share Price alongside valuation multiples.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_dividend_yield_relevant_for_Gland_Pharma_Share_Price\"><\/span><strong>Is dividend yield relevant for Gland Pharma Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Dividend yield is 0.67%, which shows the historical payout relative to the current share price. For Gland Pharma Share Price, that is a modest income signal compared with the larger focus on valuation and growth metrics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Gland_Pharma_compare_with_peer_companies\"><\/span><strong>How does Gland Pharma compare with peer companies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Compared with peers, Gland Pharma Share Price sits above Ipca Laboratories and Abbott India on P\/E, but below Anthem Biosciences and Glaxosmithkline Pharmaceuticals on return metrics. Peer comparison keeps the valuation debate grounded.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Gland_Pharma_operate_in\"><\/span><strong>What sector does Gland Pharma operate in?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. That industry context is central to Gland Pharma Share Price analysis because sector valuation and profitability benchmarks shape comparison.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Gland Pharma Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma Share Price last traded at Rs 3,050, after touching a fresh 52-week high of Rs 3,055. The stock is up 1.43% from the previous close of Rs 3,006.90 in early trade.\"}},{\"@type\":\"Question\",\"name\":\"Why did Gland Pharma Share Price touch a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"According to latest Univest figures, the fresh 52-week high is confirmed, but no company-specific catalyst is established from the price data alone. A news item on the same day discussed a broker rating and target price.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of Gland Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma has a market capitalisation of Rs 48,067.66 crore. That places Gland Pharma Share Price in a large company bracket within the healthcare universe, without changing the valuation questions that matter to investors.\"}},{\"@type\":\"Question\",\"name\":\"How is Gland Pharma Share Price valued versus its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma Share Price trades at a P\/E of 43.96 versus the same-industry median of 31.86 and a P\/B of 4.67 versus 2.93. ROCE at 14.96% is above the benchmark median of 13.61%.\"}},{\"@type\":\"Question\",\"name\":\"What do EPS and book value mean for Gland Pharma Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"EPS of Rs 68.41 shows earnings attributable to each share, while book value of Rs 644.16 shows accounting net worth per share. Both figures are important when assessing Gland Pharma Share Price alongside valuation multiples.\"}},{\"@type\":\"Question\",\"name\":\"Is dividend yield relevant for Gland Pharma Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. Dividend yield is 0.67%, which shows the historical payout relative to the current share price. For Gland Pharma Share Price, that is a modest income signal compared with the larger focus on valuation and growth metrics.\"}},{\"@type\":\"Question\",\"name\":\"How does Gland Pharma compare with peer companies?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Compared with peers, Gland Pharma Share Price sits above Ipca Laboratories and Abbott India on P\/E, but below Anthem Biosciences and Glaxosmithkline Pharmaceuticals on return metrics. Peer comparison keeps the valuation debate grounded.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Gland Pharma operate in?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That industry context is central to Gland Pharma Share Price analysis because sector valuation and profitability benchmarks shape comparison.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Gland_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Gland Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use Gland Pharma Ltd. (GLAND) live share-price page, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Track Gland Pharma Share Price on Univest for live price updates, fundamental ratios, 52-week levels, valuation context and sector comparisons. Gland Pharma Share Price pages also help readers follow the latest market update, peer comparison and company overview in one place.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gland Pharma Ltd. Share Price hit a fresh 52-week high of Rs 3,055 today and is trading at Rs 3,050, up 1.43% on the day. Market cap stands at Rs 48,067.66 crore.<\/p>\n","protected":false},"author":35,"featured_media":291073,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-291077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["291073"],"rank_math_title":["Gland Pharma Share Price Hits Fresh 52-Week High at Rs 3,055"],"rank_math_description":["Gland Pharma Share Price touched a fresh 52-week high of Rs 3,055. See today\u2019s price action, valuation metrics, sector context and peer comparison."],"rank_math_focus_keyword":["Gland Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/Gland_Pharma_Ltd_GLAND_Share_Price_Hits_Fresh_52_Week_High_at_Rs_3055_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=291077"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291077\/revisions"}],"predecessor-version":[{"id":291079,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/291077\/revisions\/291079"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/291073"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=291077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=291077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=291077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}